FDA
-
-
-
-
-
-
-
Glaukos Announces First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Glaukos breaks ground on $80 million Alabama manufacturing facility
-
-
-
-
-
-
-
Glaukos Announces EU MDR Certification for iStent infiniteĀ® and Other Leading MIGS Therapies
-
-
-
-
-
-
-
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30
-
-
-
-
-
-
-
Glaukos Announces Positive Clinical Updates for its iDoseĀ® Sustained-Release Procedural Pharmaceutical Platform
-
326,457 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

